161 related articles for article (PubMed ID: 23460944)
1. CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.
Kraeva N; Zvaritch E; Frodis W; Sizova O; Kraev A; MacLennan DH; Riazi S
Anesthesiology; 2013 Feb; 118(2):344-9. PubMed ID: 23460944
[TBL] [Abstract][Full Text] [Related]
2. Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke.
Protasi F; Paolini C; Dainese M
J Physiol; 2009 Jul; 587(Pt 13):3095-100. PubMed ID: 19417098
[TBL] [Abstract][Full Text] [Related]
3. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.
Dainese M; Quarta M; Lyfenko AD; Paolini C; Canato M; Reggiani C; Dirksen RT; Protasi F
FASEB J; 2009 Jun; 23(6):1710-20. PubMed ID: 19237502
[TBL] [Abstract][Full Text] [Related]
4. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
Brandom BW; Bina S; Wong CA; Wallace T; Visoiu M; Isackson PJ; Vladutiu GD; Sambuughin N; Muldoon SM
Anesth Analg; 2013 May; 116(5):1078-1086. PubMed ID: 23558838
[TBL] [Abstract][Full Text] [Related]
5. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
[TBL] [Abstract][Full Text] [Related]
6. Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.
Michelucci A; Paolini C; Boncompagni S; Canato M; Reggiani C; Protasi F
FASEB J; 2017 Aug; 31(8):3649-3662. PubMed ID: 28465322
[TBL] [Abstract][Full Text] [Related]
7. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations.
Sambuughin N; Sei Y; Gallagher KL; Wyre HW; Madsen D; Nelson TE; Fletcher JE; Rosenberg H; Muldoon SM
Anesthesiology; 2001 Sep; 95(3):594-9. PubMed ID: 11575529
[TBL] [Abstract][Full Text] [Related]
8. Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all.
Protasi F; Paolini C; Canato M; Reggiani C; Quarta M
J Muscle Res Cell Motil; 2011 Dec; 32(4-5):257-70. PubMed ID: 22130610
[TBL] [Abstract][Full Text] [Related]
9. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
[TBL] [Abstract][Full Text] [Related]
10. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
Steinfath M; Singh S; Scholz J; Becker K; Lenzen C; Wappler F; Köchling A; Roewer N; Schulte am Esch J
J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940
[TBL] [Abstract][Full Text] [Related]
11. Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia.
Sun Z; Wang L; Han L; Wang Y; Zhou Y; Li Q; Wu Y; Talabieke S; Hou Y; Wu L; Liu R; Fu Z; You H; Li BY; Zheng Y; Luo D
Circulation; 2021 Sep; 144(10):788-804. PubMed ID: 34162222
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia.
Stewart SL; Hogan K; Rosenberg H; Fletcher JE
Clin Genet; 2001 Mar; 59(3):178-84. PubMed ID: 11260227
[TBL] [Abstract][Full Text] [Related]
13. A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release.
D'Adamo MC; Sforna L; Visentin S; Grottesi A; Servettini L; Guglielmi L; Macchioni L; Saredi S; Curcio M; De Nuccio C; Hasan S; Corazzi L; Franciolini F; Mora M; Catacuzzeno L; Pessia M
PLoS One; 2016; 11(5):e0155516. PubMed ID: 27196359
[TBL] [Abstract][Full Text] [Related]
14. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
15. Oxygen Consumption and Basal Metabolic Rate as Markers of Susceptibility to Malignant Hyperthermia and Heat Stroke.
Serano M; Pietrangelo L; Paolini C; Guarnier FA; Protasi F
Cells; 2022 Aug; 11(16):. PubMed ID: 36010545
[TBL] [Abstract][Full Text] [Related]
16. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
17. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
Monnier N; Lunardi J
Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
[TBL] [Abstract][Full Text] [Related]
18. An Association between OXPHOS-Related Gene Expression and Malignant Hyperthermia Susceptibility in Human Skeletal Muscle Biopsies.
Chang L; Motley R; Daly CL; Diggle CP; Hopkins PM; Shaw MA
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542460
[TBL] [Abstract][Full Text] [Related]
19. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
Steinfath M; Scholz J; Singh S; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
